Kiran Mazumdar-Shaw
Founder, Chair And Managing Director,, Biocon
$3.39B
as of 10/04/24
About Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw, one of India's richest self-made women, founded biopharmaceutical firm Biocon, in 1978. The firm has successfully forayed into the lucrative U.S. market.
The company has Asia's largest insulin factory in Malaysia's Johor region.
Biocon Biologics acquired the biosimilars business of Viatris in 2022 for $3.3 billion.
In 2022, the Central Bureau of Investigation arrested a Biocon Biologics executive and four others in an alleged bribery case. The company denied any wrongdoing.
Biocon-backed cancer therapy company Bicara Therapeutics raised $362 million in an IPO on the Nasdaq in September 2024.
Personal stats
Citizenship
IndiaSource of wealth
BiopharmaceuticalsResidence
Bangalore, IndiaMarital status
WidowedBirth date
03/23/53 (age 71)Education
Bachelor of Arts/Science, Bangalore University; Master of Science, Melbourne UniversitySelf-made
self-madeKiran Mazumdar-Shaw’s fortune is worth
56K
troy ounces of gold
52K
median U.S. household
34K
median U.S. income
0.068%
U.S. credit card volume
0.014%
GDP of the United States
0.01%
United States debt
Net worth history
Annual ranking
Did you know?
Her philanthropic initiative, Mazumdar Shaw Medical Center, aims to create a sustainable, affordable cancer care model.
Net worth over time
Real-time ranking
Financial assets
NASDAQ | BCAX-US
Bicara TherapeuticsBSE INDIA | 532523-IN
BioconBSE INDIA | 539551-IN
Narayana HrudayalayaImages © Forbes.com. All rights reserved.